UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antioxidant defense enzymes in multiple sclerosis: A 5‐year follow‐up study

European journal of neurology, 2023-08, Vol.30 (8), p.2338-2347

2023

Volltextzugriff (PDF)

Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study

PloS one, 2013-01, Vol.8 (1), p.e53996-e53996

2013

Volltextzugriff (PDF)

Impact of DYRK1A Expression on TNNT2 Splicing and Daunorubicin Toxicity in Human iPSC-Derived Cardiomyocytes

Cardiovascular toxicology, 2022-08, Vol.22 (8), p.701-712

2022

Volltextzugriff (PDF)

Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event

Journal of neurology, neurosurgery and psychiatry, 2013-11, Vol.84 (11), p.1186-1191

2013

Volltextzugriff (PDF)

Metabolomic profiles in relapsing–remitting and progressive multiple sclerosis compared to healthy controls: a five-year follow-up study

Metabolomics, 2023-04, Vol.19 (5), p.44-44, Article 44

2023

Volltextzugriff (PDF)

Exploratory 5-year follow-up study of retinol, tocopherols, and carotenoids in multiple sclerosis

Multiple sclerosis and related disorders, 2024-01, Vol.81, p.105143-105143, Article 105143

2024

Volltextzugriff (PDF)

Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB11501 status in multiple sclerosis patients

PloS one, 2011-02, Vol.6 (2), p.e16802-e16802

2011

Volltextzugriff (PDF)

Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes

Journal of neurology, neurosurgery and psychiatry, 2014-08, Vol.85 (8), p.859-864

2014

Volltextzugriff (PDF)

Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor

Human molecular genetics, 2007-11, Vol.16 (22), p.2659-2668

2007

Volltextzugriff (PDF)

Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis

Journal of neuroimmunology, 2012-02, Vol.243 (1), p.61-68

2012

Volltextzugriff (PDF)

Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: Results from the Multi-Center SET study

Journal of neuroimmunology, 2014-08, Vol.273 (1), p.58-64

2014

Volltextzugriff (PDF)

Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromes

Journal of neuroimmunology, 2013-10, Vol.263 (1), p.121-127

2013

Volltextzugriff (PDF)

Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study

The Journal of steroid biochemistry and molecular biology, 2014-09, Vol.143, p.424-433

2014

Volltextzugriff (PDF)

HLA DRB11501 is only modestly associated with lesion burden at the first demyelinating event

Journal of neuroimmunology, 2011-07, Vol.236 (1), p.76-80

2011

Volltextzugriff (PDF)

Dynamics of interferon-β modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-β neutralizing antibodies

Journal of neuroimmunology, 2006-07, Vol.176 (1), p.125-133

2006

Volltextzugriff (PDF)

Interferon-β modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients

Multiple sclerosis, 2006-10, Vol.12 (5), p.541-550

2006

Volltextzugriff (PDF)

Pharmacogenetics of MXA SNPs in interferon-β treated multiple sclerosis patients

Journal of neuroimmunology, 2007-01, Vol.182 (1), p.236-239

2007

Volltextzugriff (PDF)

Analysis of the intracellular traffic of IgG in the context of Down syndrome (trisomy 21)

Scientific reports, 2021-05, Vol.11 (1), p.10981-12, Article 10981

2021

Volltextzugriff (PDF)

Interferon inhibitory activity in patients with multiple sclerosis

Archives of neurology (Chicago), 2006-11, Vol.63 (11), p.1579

2006

Volltextzugriff (PDF)

Genomic effects of once-weekly, intramuscular interferon-β1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients

Journal of neuroimmunology, 2008, Vol.205 (1), p.113-125

2008

Volltextzugriff (PDF)

The rs2030324 SNP of brain-derived neurotrophic factor ( BDNF) is associated with visual cognitive processing in multiple sclerosis

Pathophysiology (Amsterdam), 2011-02, Vol.18 (1), p.43-52

2011

Volltextzugriff (PDF)

Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients

Journal of neuroimmunology, 2008-12, Vol.205 (1-2), p.113-125

2008

Volltextzugriff (PDF)

Genomic effects of once-weekly, intramuscular interferon- beta 1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients

Journal of neuroimmunology, 2008-12, Vol.205 (1-2), p.113-125

2008

Volltextzugriff (PDF)

Could high lithium levels in tobacco contribute to reduced risk of Parkinson's disease in smokers?

Journal of the neurological sciences, 2019-02, Vol.397, p.179-180

2019

Volltextzugriff (PDF)

Lipid profiles are associated with lesion formation over 24months in interferon- beta treated patients following the first demyelinating event

Journal of neurology, neurosurgery and psychiatry, 2013-11, Vol.84 (11), p.1186-1191

2013

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antioxidant defense enzymes in multiple sclerosis: A 5‐year follow‐up study

Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study

Impact of DYRK1A Expression on TNNT2 Splicing and Daunorubicin Toxicity in Human iPSC-Derived Cardiomyocytes

Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event

Metabolomic profiles in relapsing–remitting and progressive multiple sclerosis compared to healthy controls: a five-year follow-up study

Exploratory 5-year follow-up study of retinol, tocopherols, and carotenoids in multiple sclerosis

Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB11501 status in multiple sclerosis patients

Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes

Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor

Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis

Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: Results from the Multi-Center SET study

Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromes

Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study

HLA DRB11501 is only modestly associated with lesion burden at the first demyelinating event

Dynamics of interferon-β modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-β neutralizing antibodies

Interferon-β modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients

Pharmacogenetics of MXA SNPs in interferon-β treated multiple sclerosis patients

Analysis of the intracellular traffic of IgG in the context of Down syndrome (trisomy 21)

Interferon inhibitory activity in patients with multiple sclerosis

Genomic effects of once-weekly, intramuscular interferon-β1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients

The rs2030324 SNP of brain-derived neurotrophic factor ( BDNF) is associated with visual cognitive processing in multiple sclerosis

Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients

Genomic effects of once-weekly, intramuscular interferon- beta 1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients

Could high lithium levels in tobacco contribute to reduced risk of Parkinson's disease in smokers?

Lipid profiles are associated with lesion formation over 24months in interferon- beta treated patients following the first demyelinating event

Suchergebnisse filtern